Table 3.
Characteristic | No. of patients | Median OS, years | Hazard ratio (95% CI) | P |
---|---|---|---|---|
RRM1 expression: | ||||
high | 42 | 2.1 | 0.94 | 0.81 |
low | 42 | 2.0 | (0.57, 1.54) | |
Age, years: | ||||
< 70 | 43 | 5.4 | 2.19 | 0.002 |
≥ 70 | 41 | 1.3 | (1.32, 3.63) | |
Gender: | ||||
male | 63 | 2.0 | 0.95 | 0.86 |
female | 21 | 2.0 | (0.55, 1.66) | |
T stage: | ||||
T2 | 28 | 4.0 | 0.68 (0.40, 1.15) |
0.15 |
T3 | 36 | 1.4 | 1.11 (0.67, 1.84) |
0.68 |
T4 | 20 | 1.2 | 1.46 (0.82, 2.57) |
0.2 |
Nodal involvement: | ||||
positive | 26 | 1.8 | 0.89 | 0.66 |
negative | 58 | 2.3 | (0.52, 1.51) | |
Stage group | ||||
II | 25 | 4.3 | 0.62 (0.36, 1.08) |
0.091 |
III | 32 | 1.2 | 1.34 (0.80, 2.23) |
0.26 |
IV | 27 | 1.8 | 1.20 (0.71, 2.02) |
0.51 |